Free Trial

POET Technologies (NASDAQ:POET) Stock Price Up 9.7% - Time to Buy?

POET Technologies logo with Computer and Technology background

Shares of POET Technologies Inc. (NASDAQ:POET - Get Free Report) rose 9.7% on Monday . The company traded as high as $6.68 and last traded at $6.88. Approximately 421,274 shares changed hands during trading, a decline of 75% from the average daily volume of 1,691,603 shares. The stock had previously closed at $6.27.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded shares of POET Technologies from a "strong sell" rating to a "hold" rating in a report on Thursday, May 22nd.

Check Out Our Latest Research Report on POET Technologies

POET Technologies Price Performance

The stock has a 50 day moving average of $5.05 and a 200-day moving average of $4.57.

POET Technologies (NASDAQ:POET - Get Free Report) last announced its quarterly earnings data on Wednesday, May 21st. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.17. The firm had revenue of $0.17 million during the quarter, compared to analysts' expectations of $0.56 million. As a group, analysts forecast that POET Technologies Inc. will post -0.45 earnings per share for the current fiscal year.

Institutional Trading of POET Technologies

Large investors have recently made changes to their positions in the business. Tyler Stone Wealth Management raised its holdings in shares of POET Technologies by 24.1% during the first quarter. Tyler Stone Wealth Management now owns 349,800 shares of the company's stock worth $1,322,000 after purchasing an additional 68,000 shares during the last quarter. Strengthening Families & Communities LLC purchased a new position in shares of POET Technologies during the 1st quarter valued at about $26,000. Virtu Financial LLC lifted its holdings in shares of POET Technologies by 120.5% in the 1st quarter. Virtu Financial LLC now owns 47,351 shares of the company's stock valued at $179,000 after buying an additional 25,879 shares during the period. US Bancorp DE boosted its stake in shares of POET Technologies by 12,881.1% in the first quarter. US Bancorp DE now owns 28,169 shares of the company's stock worth $106,000 after buying an additional 27,952 shares during the last quarter. Finally, Baader Bank Aktiengesellschaft acquired a new stake in POET Technologies during the first quarter worth about $47,000. 1.99% of the stock is owned by hedge funds and other institutional investors.

About POET Technologies

(Get Free Report)

POET Technologies Inc designs, develops, manufactures, and sells discrete and integrated opto-electronic solutions in Canada, the United States, Singapore, and China. It offers integration solutions based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques.

Featured Stories

Should You Invest $1,000 in POET Technologies Right Now?

Before you consider POET Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and POET Technologies wasn't on the list.

While POET Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines